TUMS EXTRA SURT TAB MAST C8X3 LIDOCAINA 10.00 G PRINCIPIO ACTIVO: SOMATROPINA

Description

PRINCIPIO ACTIVO: SOMATROPINA

FORMA FARMACÉUTICA: 1 ENJUAGUE BUCAL

KADCYLA® 160 mg es un medicamento de uso intravenoso que contiene Trastuzumab Emtansina (T-DM1)

PRINCIPIO ACTIVO: METAMIZOL

TUMS EXTRA SURT TAB MAST C8X3 LIDOCAINA 10.00 G PRINCIPIO ACTIVO: SOMATROPINA

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy